Bristol-Myers Squibb | BMY - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.68B 439M 2026-03
ALKERMES USD 102.36M 5.59M 2026-03
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Biogen USD 358.5M 73.5M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Coherus Biosciences USD 9.91M 14.98M 2025-12
Drreddys Laboratories INR 22.36B 21.91B 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
J&J USD 9.22B 1.24B 2026-06
Medtronic USD 2.57B 12M 2025-12
Merck USD 3.86B 541M 2026-03
Novartis USD 4.32B 134M 2026-03
Novo Nordisk DKK 14.8B 4.96B 2026-03
Perrigo USD 434.8M 39.7M 2026-03
Pfizer USD 4.51B 734M 2026-03
Phibro Animal Health USD 129.64M 3.65M 2026-03
Prestige Brands USD 22.79M 20.15M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 22.71B 219M 2026-03
Sanofi EUR 22.71B 219M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03
Zoetis USD 507M 20M 2026-03